22.15
Definium Therapeutics Inc 주식(DFTX)의 최신 뉴스
Definium Therapeutics (DFTX) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Top Definium Therapeutics (DFTX) Competitors 2026 - MarketBeat
Definium Therapeutics Sees Insider Stock Selling - 富途牛牛
DFTX: Definium Therapeutics, Inc.Income Statment - Zacks Investment Research
All News for DFTX : Definium Therapeutics, Inc. - Zacks Investment Research
symbol__ Stock Quote Price and Forecast - CNN
DFTX: Piper Sandler Initiates Coverage with Overweight Rating | - GuruFocus
Definium Therapeutics stock hits 52-week high at 21.99 USD - Investing.com
Definium Therapeutics stock hits 52-week high at 21.99 USD By Investing.com - Investing.com UK
Piper Sandler Initiates Definium Therapeutics at Overweight - marketscreener.com
Piper Sandler initiates Definium stock with Overweight rating By Investing.com - Investing.com South Africa
Piper Sandler initiates Definium stock with Overweight rating - Investing.com UK
Investment bank Piper Sandler announced the official initiation of coverage on biopharmaceutical company Definium Therapeutics Inc, assigning it an "Overweight" rating. - Bitget
Definium Therapeutics to Participate at Upcoming Investor Conferences and Events - marketscreener.com
Definium Therapeutics Inc (DFTX) Stock Price Quote Today & Current Price Chart | Capital.com UAE - Capital.com
Definium Therapeutics, Inc. (DFTX) stock price, news, quote and history - Yahoo Finance UK
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Price performance - Yahoo Finance Singapore
Do Definium Therapeutics’ (DFTX) New Hires Hint At A Deeper Bet On Anxiety Treatments? - Sahm
Can Definium Therapeutics (DFTX) Turn GAD Prevalence And DT120 Breakthrough Status Into Durable Advantage? - Yahoo Finance
Total non-current liabilities of Definium Therapeutics, Inc. – NASDAQ:DFTX - TradingView — Track All Markets
Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (DFTX) and Eli Lilly & Co (LLY) - The Globe and Mail
Definium Therapeutics stock hits 52-week high at 19.78 USD By Investing.com - Investing.com Canada
Definium Therapeutics (NASDAQ:DFTX) Sets New 52-Week HighHere's Why - MarketBeat
Definium Therapeutics stock hits 52-week high at 19.78 USD - Investing.com
LifeSci Capital Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $32 - Moomoo
New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States - BioSpace
Definium Therapeutics (DFTX) Study Highlights Rising GAD Rates i - GuruFocus
Anxiety disorder prevalence rises to 6.6% in U.S., study finds By Investing.com - Investing.com Australia
Anxiety disorder prevalence rises to 6.6% in U.S., study finds - Investing.com
Definium Therapeutics Inc (DFTX) Stock Price Quote Today & Current Price Chart - Capital.com
Definium Therapeutics Inc (DFTX) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Definium Therapeutics Announces New Employee Inducement Grants - The Norfolk Daily News
A Look At Definium Therapeutics (DFTX) Valuation As Investor Day Highlights Late Stage DT120 ODT Pipeline - Sahm
Definium Therapeutics, Inc. (NASDAQ:DFTX) Short Interest Update - Defense World
Definium Therapeutics Insider Sold Shares Worth $451,241, According to a Recent SEC Filing - marketscreener.com
Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026 - BioSpace
Definium Therapeutics CMO Karlin sells $148k in shares By Investing.com - Investing.com Australia
Definium Therapeutics CEO Barrow sells $451k in shares By Investing.com - Investing.com India
자본화:
|
볼륨(24시간):